Evidence map›Paper›PMID 36505715›Full record

ArticleRSC advances2022

Generation of novel Diels-Alder reactions using a generative adversarial network.

Sheng Li, Xinqiao Wang, Yejian Wu, Hongliang Duan, Lan Tang

Abstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sheng LiCollege of Pharmaceutical Sciences, Zhejiang University of Technology Hangzhou 310014 P. R. China tanglan@zjut.edu.cn.ORCID https://orcid.org/0000-0002-7533-721X
Xinqiao WangArtificial Intelligence Aided Drug Discovery Institute, College of Pharmaceutical Sciences, Zhejiang University of Technology Hangzhou 310014 P. R. China.
Yejian WuArtificial Intelligence Aided Drug Discovery Institute, College of Pharmaceutical Sciences, Zhejiang University of Technology Hangzhou 310014 P. R. China.ORCID https://orcid.org/0000-0002-9581-2479
Hongliang DuanArtificial Intelligence Aided Drug Discovery Institute, College of Pharmaceutical Sciences, Zhejiang University of Technology Hangzhou 310014 P. R. China.
Lan TangCollege of Pharmaceutical Sciences, Zhejiang University of Technology Hangzhou 310014 P. R. China tanglan@zjut.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep learning has enormous potential in the chemical and pharmaceutical fields, and generative adversarial networks (GANs) in particular have exhibited remarkable performance in the field of molecular generation as generative models. However, their application in the field of organic chemistry has been limited; thus, in this study, we attempt to utilize a GAN as a generative model for the generation of Diels-Alder reactions. A MaskGAN model was trained with 14 092 Diels-Alder reactions, and 1441 novel Diels-Alder reactions were generated. Analysis of the generated reactions indicated that the model learned several reaction rules in-depth. Thus, the MaskGAN model can be used to generate organic reactions and aid chemists in the exploration of novel reactions.

Identifiers

PMID36505715
PMCPMC9693912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.